Compound information
- Natural Products
- ZC1190874
- Molecular Formula
- C14H18N4O
- Molecular Weight
- 258.148061196 g/mol
- Structure
-
- IUPAC Name
- 1-[(1R)-1-methylpropyl]-3-(1-phenylpyrazol-4-yl)urea
- InChI
- InChI=1S/C14H18N4O/c1-3-11(2)16-14(19)17-12-9-15-18(10-12)13-7-5-4-6-8-13/h4-11H,3H2,1-2H3,(H2,16,17,19)/t11-/m1/s1
- InChI Key
- DRAUOZQUBXXWBW-LLVKDONJSA-N
- SMILES
- CC[C@@H](C)NC(=O)Nc1cnn(-c2ccccc2)c1
- Source
- ZINC000071921416
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
| Property | Value | Property | Value |
|---|---|---|---|
| Heavy Atom Count | 19 | Ring Count | 2 |
| Heteroatom Count | 5 | Rotatable Bond Count | 4 |
| Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 2 |
| Topological Polar Surface Area | 58.95 Å2 | LogP | 2.747 |
| LogS | -3.076 | LogD | 3.498 |
Absorption
| Property | Value | Property | Value |
|---|---|---|---|
| Pgp inhibitor | 0.144 | Pgp substrate | 0.028 |
| HIA | 0.969 | F20 % | 0.993 |
| F30 % | 0.91 | Caco-2 | -4.863 |
| MDCK | -5.398 |
Distribution
| Property | Value | Property | Value |
|---|---|---|---|
| BBB Penetration | 0.579 | PPB | 88.252 |
| VD | 1.058 | Fu | 0.872 |
Metabolism
| Property | Value | Property | Value |
|---|---|---|---|
| CYP1A2 inhibitor | 0.988 | CYP1A2 substrate | 0.802 |
| CYP2A6 substrate | 0.79 | CYP2B6 substrate | 0.713 |
| CYP2C19 inhibitor | 0.644 | CYP2C19 substrate | 0.874 |
| CYP2C8 substrate | 0.694 | CYP2C9 inhibitor | 0.568 |
| CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.03 |
| CYP2D6 substrate | 0.998 | CYP2E1 substrate | 0.88 |
| CYP3A4 inhibitor | 0.021 | CYP3A4 substrate | 0.999 |
Excretion
| Property | Value | Property | Value |
|---|---|---|---|
| T1/2 | 0.553 | CL | 9.094 |
Toxicity
| Property | Value | Property | Value |
|---|---|---|---|
| hERG Blockers | 0.009 | Hepatotoxicity | 0.332 |
| Mutagenicity | 0.004 | Rat Oral Acute Toxicity | 0.022 |
| FDAMDD | 0.441 | Skin Sensitization | 0.881 |
| Carcinogenicity | 0.153 | Eye Corrosion | 0.003 |
| Eye Irritation | 0.113 | Respiratory Toxicity | 0.71 |
Environmental Toxicity
| Property | Value | Property | Value |
|---|---|---|---|
| Bioconcentration Factors | -0.079 | IGC50 | 2.977 |
| LC50FM | 3.557 | LC50DM | 3.837 |
Tox21 Pathway
| Property | Value | Property | Value |
|---|---|---|---|
| NR-AR | 0.134 | NR-AR-LBD | 0.232 |
| NR-AhR | 0.068 | NR-Aromatase | 0.041 |
| NR-ER | 0.323 | NR-ER-LBD | 0.238 |
| NR-PPAR-gamma | 0.367 | SR-ARE | 0.105 |
| SR-ATAD5 | 0.375 | SR-HSE | 0.046 |
| SR-MMP | 0.154 | SR-p53 | 0.022 |
Similar covalent drugs
No similar covalent drugs found for this compound.